Provider review
WeightlessRx review
Will not restart your titration from week one if you switch to it.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$174/mo month-to-month semaglutide, less on a three-month plan
Visit WeightlessRxAnd publishes the committed and month-to-month rates together on every card.
Price as published
WeightlessRx
$174/mo month-to-month semaglutide, less on a three-month plan
- Vs median
- $1/mo below the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Two things make this worth reading and neither is the headline figure. The first is that both rungs are published on every card, so the decision to commit or stay flexible can be made on the page rather than discovered at a checkout — and the month-to-month rate is roughly double the committed one, which is the number that actually applies if you are starting cautiously. The second is a policy most providers do not state at all: if you are already on a GLP-1 and switching, your clinician can continue you at or near your current titration level rather than restarting you from week one. Anyone who has changed providers mid-course knows what that is worth, because restarting a titration means paying for weeks of a dose you already passed through and living with the side effects again. Lock in your price for life is attached to both products, which is a stronger promise than a flat-dose one because it covers renewals as well as dose increases. Both figures are floors and no milligram appears, so the promise cannot be checked against a quantity.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You are switching providers mid-course and do not want to restart your titration
- You want both the committed and flexible rates in front of you before choosing
- You want a price locked against renewals as well as dose increases
Look elsewhere if
- You want to stay month-to-month — that rate is roughly double the headline
- You want a rate rather than a starting point
- You want a dose behind the number
What it actually costs
Price as published
$174/mo month-to-month semaglutide, less on a three-month plan
- Vs median
- $1/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. No low-dose product, but two things matter more here than that. Both price options are published on every card, so the commit-or-not decision is made on the page rather than at a checkout. And the titration policy is stated: a switching patient is continued at or near their existing level rather than restarted from week one, which is the difference between repeating weeks of a dose already passed and picking up where they left off. The price lock covers renewals as well as dose increases.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Included
- Labs
- Not required
- Pricing
- Flat at every dose
What it does well
- Publishes the committed and month-to-month rates together on every card.
- States that a switching patient is not restarted from week one of titration.
- Locks the price for life, covering renewals as well as dose increases.
Pharmacy, labs and oversight
WeightlessRx does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
3 of 4 published openly
What WeightlessRx publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsOne price at every dose, so the bill is knowable before you titrate.
- Published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Two things make this row worth reading and neither is the headline. The first is that both rungs are published on every card, so the commit-or-not decision can be made on the page rather than at a checkout, and the month-to-month rate is roughly double the committed one — which is the number that actually applies to anyone starting cautiously. The second is a policy most providers do not state at all: a switching patient can be continued at or near their existing titration level rather than restarted from week one. Anyone who has moved providers mid-course knows what that is worth, because restarting a titration means weeks of a dose that was already passed and a bill for each of them. Lock in your price for life is attached to both products, which is a stronger promise than a flat-dose one since it covers renewals as well as dose increases. Both figures are floors and no milligram appears, so the promise cannot be checked against a quantity.
The honest cons
The month-to-month rate is roughly double the advertised committed one.
- Both figures are floors with nothing above them published.
- No milligram appears, so the price-lock cannot be checked against a quantity.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
WeightlessRx is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way WeightlessRx does. Both are partners: we may earn a commission if you start care through these links.
Partner
Sprout Health
$149 sema · $199 tirz
Standard plan, self-directed low dose
FDA warning letter · Sprout Health · September 2025 · addressed to Sprout Health Partners LLC dba Sprout Health. Details in our review.
Partner
Bodybuilding Health+
$179/mo sema · $209/mo tirz
Standard plan, self-directed low dose
Where this sits
#370 of 548
Ordered with the companies that pay us first, and WeightlessRx is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
HealthRX
$190/mo sema · $239/mo tirz (monthly plan)
- Vs median
- $15/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the HealthRX review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.